InnovaRx Innova Health Strategies

E34.0

Carcinoid syndrome

Not billable — category only FY2026 2025-10-01 → 2026-09-30
Exclusions 4 never code together
E34code
Excludes1
  • pseudohypoparathyroidism (E20.1)E20.1
E20-E35block
Excludes1
  • galactorrhea (N64.3)N64.3
  • gynecomastia (N62)N62
E00-E89chapter
Excludes1
  • transitory endocrine and metabolic disorders specific to newborn (P70-P74)P70-P74

Excludes1 — never code together. The excluded condition and this one are mutually exclusive.

Instructional notes 4
E34.0code
Code also
  • the underlying disorder, such as:
  • primary neuroendocrine tumors (C7A.-)C7A.-C7A.-
  • secondary neuroendocrine tumors (C7B.-)C7B.-C7B.-
E00-E89chapter
Notes
  • All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.E05.8E07.0E16-E31E34.-
Index entries leading here filed at null

No alphabetic index entry points at this code.

Alongside this code 7 same parent — E34
Subordinate codes 3
Medications 1

MED-RT files conditions by MeSH, which carves the world differently from ICD-10. These are name matches on this code's description, offered as candidates — not as an assertion that they are this code.

Additional references
AHA Coding Clinic® Licence required

Official coding advice for this code. Published by the American Hospital Association. Not included in this installation.

Risk adjustment

Maps to no condition category in any loaded model.

Presence is a property of the code. Untick a model to hide it everywhere.

This code

Billable
no
Code set
FY2026
Parent
E34
Block
E20-E35
Siblings
7
Subordinate
3

Present FY2024–FY2027.